Explore the latest in gynecologic cancer, including recent advances in the management of cervical, endometrial, and ovarian cancers.
This Medical News article discusses updates in the American Cancer Society’s cervical cancer screening guideline.
This single-arm, phase 2 nonrandomized clinical trial assesses the efficacy and safety of combined pembrolizumab, bevacizumab, and oral metronomic cyclophosphamide in women with recurrent platinum-sensitive, platinum-resistant, or refractory epithelial ovarian, fallopian tube, or primary peritoneal cancer.
This cohort study develops and validates deep learning models to understand public perceptions of human papillomavirus (HPV) vaccines from the perspective of behavior change theories using data from social media.
This cohort study examines the diagnostic accuracy, performance characteristics, and morbidity associated with sentinel lymph node biopsy in patients with intermediate- and high-grade endometrial cancer.
This cross-sectional study assesses whether the rate of positive BRCA test results changed between 2008 and 2018 among older women in the United States.
This open-label phase 1 study assesses the antitumor activity, tolerability, and safety of dostarlimab for patients with recurrent or advanced deficient mismatch repair endometrial cancer that has progressed after platinum-containing chemotherapy.
This case report describes a woman in her 20s who underwent chemoradiation for cervical carcinoma and subsequently presented with headaches and right-sided temporomandibular joint pain.
This genetic association study uses fine mapping of the major histocompatibility complex (MHC) region by human leukocyte antigen imputation to determine whether the HLA-B*52:01 allele is associated with cervical cancer (CC) in Japanese women.
This JAMA Insights review summarizes 2020 consensus guidelines on management of minimally abnormal cervical cancer screening results, including no abnormal pathology, atypical squamous cells of undetermined significance (ASCUS), and low-grade squamous intraepithelial lesion (LSIL) with and without positive high-risk HPV testing.
This cancer epidemiology study characterizes lifetime cervical cancer screening prevalence in low- and middle-income countries overall and by region; per capita gross domestic product; and patient rurality, education, and household wealth.
This randomized clinical trial examines the efficacy of weekly paclitaxel with or without bevacizumab as treatment for relapsed sex cord-stromal tumors and whether the addition of bevacizumab to weekly paclitaxel improves 6-month progression-free rates.
This diagnostic test validates a metabolomics-based classification algorithm as a screening test for endometrial carcinoma.
This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
This cross-sectional study examines responses from a large, nationally representative telephone survey of older adults in the US to determine rates of screening for colorectal, cervical, or breast cancer after recommended upper age limits.
This diagnostic study develops a machine learning tool for use in preoperative noninvasive identification of lymph metastasis on magnetic resonance imaging in patients with cervical cancer.
This cohort study assesses whether TP53 clonal variants can be detected in Papanicolaou test samples from women later diagnosed with high-grade serous epithelial ovarian cancer (HGS-EOC).
This case-control study examines the association of polygenic risk scores with changes in breast cancer risk in women who are carriers of pathogenic variants in breast cancer susceptibility genes.
This cohort study uses data from a medical record review of a dermatogynecology practice to describe the association between reduced recurrence of vulvar squamous cell carcinoma and use of topical corticosteroids in the treatment of vulvar lichen sclerosus.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: